NCT07622654

Brief Summary

This study aims to investigate the effect of Emotion-Focused Acceptance and Commitment Therapy (ACT) group psychotherapy on obsessive-compulsive disorder (OCD) symptom severity. Participants with OCD will be randomly assigned to either an ACT-based group psychotherapy arm or a supportive group psychotherapy arm. Each arm consists of 10 to 12 weekly sessions of 2 hours. Symptom severity, psychological flexibility, emotional awareness, functioning and quality of life will be assessed before and after the intervention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2026

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2026

Completed
Last Updated

June 3, 2026

Status Verified

May 1, 2026

Enrollment Period

8 months

First QC Date

May 26, 2026

Last Update Submit

May 30, 2026

Conditions

Keywords

ACTAcceptance and Commitment TherapyObsessive-Compulsive DisorderGroup PsychotherapyOCDEmotion-Focused TherapyPsychological Flexibility

Outcome Measures

Primary Outcomes (2)

  • Obsessive-Compulsive Symptom Severity

    Change in OCD symptom severity measured by Yale-Brown Obsessive Compulsive Scale (Y-BOCS) from baseline to post-treatment.

    Baseline and 10-12 weeks (post-treatment)

  • OCD Symtom Severity- DOCS

    Change in OCD symptom severity measured by Dimensional Obsessive-Compulsive Scale (DOCS) from baseline to post treatment.

    Baseline and 10-12 weeks

Study Arms (2)

ACT-Based Group Psychotherapy

EXPERIMENTAL

Emotion-focused Acceptance and Commitment Therapy (ACT) based structured group psychotherapy targeting emotional awareness, acceptance, cognitive defusion, present-moment focus, values clarification and committed action. Groups consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.

Behavioral: Emotion-Focused Acceptance and Commitment Therapy (ACT) Group Psychotherapy

Supportive Group Psychotherapy

ACTIVE COMPARATOR

Unstructured supportive group psychotherapy aimed at providing emotional support, enhancing coping with stress and maintaining current functioning. Groups consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.

Behavioral: Emotion-Focused Acceptance and Commitment Therapy (ACT) Group Psychotherapy

Interventions

Structured group psychotherapy based on ACT principles targeting emotional awareness, acceptance of emotional experiences, cognitive defusion, present-moment focus, values clarification and committed action. Sessions are conducted face-to-face, once weekly, 2 hours per session, for 10-12 weeks.

ACT-Based Group PsychotherapySupportive Group Psychotherapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Obsessive-Compulsive Disorder according to DSM-5 criteria
  • Age between 18-65 years
  • Minimum literacy level
  • Willingness to participate and providing informed consent

You may not qualify if:

  • Age over 65 years
  • Diagnosis of alcohol or substance use disorder
  • Comorbid psychotic disorder or intellectual disability
  • Any change in psychiatric treatment (medication or psychotherapy) in the last 3 months
  • Comorbid psychiatric disorder that would impair group therapy compliance
  • History of cognitive impairment due to dementia, organic brain syndrome or other neurological/organic pathology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Goztepe Prof. Dr. Suleyman Yalcin City Hospital

Istanbul, Istanbul, 34722, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Compulsive Personality DisorderObsessive-Compulsive Disorder

Interventions

Psychotherapy, Group

Condition Hierarchy (Ancestors)

Personality DisordersMental DisordersAnxiety Disorders

Intervention Hierarchy (Ancestors)

Socioenvironmental TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Mehmet Emrah Karadere

    Goztepe Prof Dr Suleyman Yalcın City Hospital

    PRINCIPAL INVESTIGATOR
  • Kaasım Fatih Yavuz

    Baglamsal Bilimler ve Psikoterapiler Dernegi

    PRINCIPAL INVESTIGATOR
  • Beyza Baran Boz

    Goztepe Prof Dr Suleyman Yalcın City Hospital

    STUDY DIRECTOR

Central Study Contacts

Mehmet Emrah Karadere

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open-label study. Due to the nature of psychotherapy interventions, blinding of participants and therapists is not possible. Outcome assessors are not blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor of Psychiatry

Study Record Dates

First Submitted

May 26, 2026

First Posted

June 3, 2026

Study Start

October 1, 2025

Primary Completion

June 1, 2026

Study Completion

June 1, 2026

Last Updated

June 3, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations